Navigation Links
Proof that antidepressants and breastfeeding can mix
Date:4/10/2014

University of Adelaide researchers have found that women on antidepressant medication are more successful at breastfeeding their babies if they keep taking the medication, compared with women who quit antidepressants because of concerns about their babies' health.

These results have been presented this week at the 18th Perinatal Society of Australia and New Zealand (PSANZ) Annual Conference in Perth.

Using data from the Danish National Birth Cohort in Denmark, researchers in the University of Adelaide's Robinson Research Institute studied the outcomes of 368 women who were on antidepressants prior to becoming pregnant.

"We found that two thirds of the women (67%) stopped taking their antidepressant medication either after becoming pregnant or during breastfeeding," says NHMRC Early Career Fellow Dr Luke Grzeskowiak from the Robinson Research Institute.

"A third of the women (33%) continued to take antidepressant medication throughout their pregnancy and while breastfeeding, and these women were much more successful at maintaining breastfeeding up to and beyond the recommended six months.

"In contrast, those women who had stopped taking antidepressants were also more likely to stop breastfeeding within the recommended six months."

Dr Grzeskowiak says the health benefits of continued breastfeeding greatly outweigh any perceived risk to the baby from antidepressant medication.

"This is a really important message because we know that breastfeeding has immense benefits for the child and the mum herself, including a degree of protection against post-natal depression," he says.

"The amount of antidepressant medication that finds its way into a mother's breast milk is very low. On the balance of it, we believe that continuing to take antidepressant medication and maintaining regular breastfeeding will be the best outcome for both the baby and the mother."

Dr Grzeskowiak says many women struggle with decisions about what to do with medications both during pregnancy and lactation.

"If they're taking antidepressants, they should be supported and encouraged by family members, friends and healthcare professionals to continue with their medication, knowing that good breastfeeding outcomes are all-important for them and their child," he says.


'/>"/>

Contact: Dr. Luke Grzeskowiak
luke.grzeskowiak@adelaide.edu.au
University of Adelaide
Source:Eurekalert

Related biology news :

1. Another scientific proof of the difference in social perception between men and women
2. A Future-Proof Approach to Intelligent Buildings
3. Jackson Laboratory researchers provide definitive proof for receptors role in synapse development
4. Northrop Grumman Delivers Australian Automated Biometric Information System Trial Proof of Concept
5. Using graphene, scientists develop a less toxic way to rust-proof steel
6. ORNL microscopy yields first proof of ferroelectricity in simplest amino acid
7. Antidepressants for bipolar disorder
8. mTOR: A key brain signaling mechanism for rapidly acting antidepressants
9. OHSU Vollum Institute research gives new insight into how antidepressants work in the brain
10. Biochemical mapping helps explain who will respond to antidepressants
11. Do antidepressants impair the ability to extinguish fear?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading ... a new solution aimed at combatting fraud, waste and ... was introduced at the Action on Disaster Relief conference ... meeting point for UN agencies and foreign assistance organizations ... Fraud, waste and abuse are a largely unacknowledged problem ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Symic Bio, a biopharmaceutical company focused on ... therapeutics, announced today the completion of enrollment for the ... The trial will evaluate the safety and efficacy of ... of restenosis following angioplasty. "We,re pleased ... said Nathan Bachtell , M.D., Chief Medical Officer ...
(Date:2/24/2017)... NY (PRWEB) , ... February 24, 2017 , ... FireflySci, ... Founded in late 2014, FireflySci had the goal of bringing their powerful ... goal continues to shape the path that FireflySci is going on as they add ...
(Date:2/24/2017)... -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing ... Leader event to highlight new clinical data that will ... the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the Company,s ... in-person and via live webcast on Tuesday, February 28 ... the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is formalizing a ... array of biochemical analyses critical for Lead Discovery. The company’s Lead Discovery ... programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor residence times ...
Breaking Biology Technology: